Aflatoxin exposure and cytogenetic alterations in individuals from the Gambia, West Africa

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 349, Issue 2, 1996, Pages 209-217

  Miele, Mariangela ^a   Donato, Francesco ^b   Hall, Andrew J ^c   Whittle, Hilton ^d   Chapot, Brigitte ^e   Bonatti, Stefania ^a   De Ferrari, Marcella ^a   Artuso, Marina ^a   Gallerani, Elena ^a   Abbondandolo, Angelo ^a   Montesano, Ruggero ^e   Wild, Christopher P ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Aflatoxin; Biomonitoring; Cytogenetic alteration; Molecular epidemiology

Indexed keywords

AFLATOXIN;

ADULT; AFRICA; AGED; ARTICLE; BIOLOGICAL MONITORING; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GAMBIA; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MICRONUCLEUS; NORMAL HUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0030029540     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(95)00180-8     Document Type: Article

References (38)

1. Aguilar, F., C.C. Harris, T. Sun, M. Hollstein and P. Cerutti (1994) Geographic variation of p53 mutational profile in nonmalignant human liver, Science, 264, 1317-1319.
2. Albertini, R.J., J.P. O'Neill, J.A. Nicklas, N.H. Heinz and P.C. Kelleher (1985) Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes, Nature, 316, 369-371.
3. 1, Mutation Res., 322, 61-67.
4. Armitage, P. and G. Berry (1987) Statistical Methods in Medical Research, Blackwell, Oxford.
5. Bah, E., A.J. Hall and H.M. Inskip (1990) The first 2 years of the Gambian National Cancer Registry, Br. J. Cancer, 62, 647-650.
6. 1 in the human hypoxanthine guanine phosphoribosyltransferase gene, Cancer Res., 54, 4436-4441.
7. Chapot, B. and C.P. Wild (1991) ELISA for quantification of aflatoxin-albumin adducts and their application to human exposure assessment, in: M. Warhol, D. Van Velzen, and G.R. Bullock (Eds.), Techniques in Diagnostic Pathology, Vol. II, Academic, pp. 135-155.
8. Chatterjee, B. and P.K. Ghosh (1989) Constitutive heterochromatin polymorphism and chromosome damage in viral hepatitis, Mutation Res., 210, 49-57.
9. Countryman, P.I. and J.A. Heddle (1976) The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes, Mutation Res., 41, 321-332.
10. Dixon, W.J. (1993) BMDP Statistical Software Manual, Release 7.0, Berkeley, University of California Press.
11. 1 intake and urinary excretion of aflatoxin M1, Carcinogenesis, 9, 1323-1325.
12. Goto, K., S. Maeda, Y. Kano and T. Sugiyama (1978) Factors involved in differential Giemsa-staining of sister chromatids. Chromosoma, 66, 351-359.
13. 1 exposure in hepatocellular carcinoma patients from Thailand, Int. J. Cancer, 53, 51-55.
14. Hsu, I.C., R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang and C.C. Harris (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature, 350, 427-428
15. IARC (1993) Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56, IARC, Lyon, France.
16. 1 in rat bone marrow cells in vivo and their suppression by green tea, Mutation Res., 222, 253-261.
17. Kulka, U., D. Paul and M. Bauchinger (1993) Development of short-term mutagenicity test systems in vitro: metabolic activation of indirectly acting mutagens by three immortal rat hepatocyte lines, Mutagenesis, 8, 193-197.
18. Lambert, B., K. Holmberg and N. Einhorn (1984) Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma, Hum. Genet., 67, 94-98.
19. 1 and N-nitrosophenacetin, Mutation Res., 242, 219-224.
20. Lovell, D.P., D. Anderson, R. Albanese, G.E. Amphlett, G. Clare, R. Ferguson, M. Richold, D.G. Papworth, J.R.K. Savage (1989) Statistical analysis of in vivo cytogenetic assays, in: D.J. Kirkland (Ed.), Statistical Evaluation of Mutagenicity Test Data, Cambridge University Press, Cambridge, pp. 184-232.
21. 1, Proc. Natl. Acad. Sci. USA, 92, 2384-2387.
22. Merry, D.E., S. Pathak, T.C. Hsu and B.R. Brinkley (1985) Anti-kinetochore antibodies: use as probes for inactive centromeres, Am. J. Hum. Genet., 37, 425-430.
23. Moorhead, P.S., P.C. Nowell, W.J. Mellman, D.M. Battips and D.A. Hungerford (1980) Chromosome preparations of leukocytes cultured from human peripheral blood, Exp. Cell Res., 20, 613-616.
24. Nordic Study Group on the Health Risk of Chromosome Damage (1990) A Nordic data base on somatic chromosome damage in humans, Mutation Res., 241, 325-337.
25. Nuesse, M., S. Viaggi and S. Bonatti (1989) Induction of kinetochore positive and negative micronuclei in V79 cells by the alkylating agent diethylsulfate, Mutagenesis, 4, 174-178.
26. Okoye, Z.S.C., J. Riley, D.J. Judah and G.E. Neal (1990) The in vivo site of formation of a carcinogen-serum albumin adduct, Biochem. Pharmacol., 40, 2560-2562.
27. Ozturk, M. et al. (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure, Lancet, 338, 1356-1359.
28. van Poppel, G., H. Verhagen, P. van-'t-Veer and P.J. van Bladeren (1993) Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase mu, Cancer Epidemiol. Biomarkers. Prev., 2, 441-447.
29. 1 exo- and endo-epoxides by rat and human glutathione S-transferases, Chem. Res. Toxicol., 5, 470-478.
30. Reuterwall, C., L. Aringer, C.G. Elinder, A. Rannug, J.O. Levin, L. Juringe and A. Onfelt (1991) Assessment of genotoxic exposure in Swedish coke-oven work by different methods of biological monitoring, Scand. J. Work Environm. Health, 17, 123-132.
31. Ryder, R.W., H.C. Whittle, A.B.K. Sanneh, A.B. Ajdukiewicz, S. Tulloch and B. Yvonnet (1992) Persistent hepatitis B virus infection and hepatoma in The Gambia, West Africa, Am. J. Epidemiol., 136, 1122-1131.
32. Schwartz, G.G. (1990) Chromosome aberrations, in: B. Hulka, T.C. Wilkosky and J.D. Griffith (Eds.), Biological Markers in Epidemiology, Oxford University Press, Oxford, pp. 147-172.
33. Simon, D., T. London, H.-W.L. Hann and B.B. Knowles (1991) Chromosome abnormalities in peripheral blood cells of hepatitis B virus chronic carrier, Cancer Res., 51, 6176-6179.
34. Vine, M.F. (1990) Micronuclei. in: B. Hulka, T.C. Wilkosky and J.D. Griffith (Eds.), Biological Markers in Epidemiology, Oxford University Press, Oxford, pp. 124-146.
35. Wild, C.P., D. Umbenhauer, B. Chapot and R. Montesano (1986) Monitoring of individual human exposure to aflatoxins (AF) and N-nitrosamines (NNO) by immunoassays, J. Cell. Biochem., 30, 171-179.
36. Wild, C.P., Y.-Z. Jiang, S.J. Allen, L.A.M. Jansen, A.J. Hall and R. Montesano (1990) Aflatoxin-albumin adducts in human sera from different regions of the world, Carcinogenesis, 11, 2271-2274.
37. Wild, C.P., G.J. Hudson, G. Sabbioni, B. Chapot, A.J. Hall, G.N. Wogan, H. Whittle, R. Montesano and J.D. Groopman (1992) Dietary intake of aflatoxins and the level of albumin bound aflatoxin in peripheral blood in The Gambia, West Africa, Cancer Epidemiol. Biol. Prev., 1, 229-234.
38. Wild, C.P., L.A.M. Jansen, L. Cova and R. Montesano (1993) Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial aetiopathogenesis of primary hepatocellular carcinoma (PHC) with particular reference to hepatitis B virus (HBV). Environ. Health Pers., 99, 115-122.